Use of an ester of inositoltrisphosphate for the treatment of inflammatory conditions

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5866557
SERIAL NO

08640785

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the use of an ester of inositoltrisphosphate for the preparation of a medicament for preventing, alleviating or combatting inflammatory conditions in mammals including man. Injury or destruction of tissues should be understood as damage to an aggregation of specialized cells with a particular function both internally and externally in the body, such as different organs or parts of these, vessels, skin etc. Tissue damage involves a complex series of events such as dilatation of vessel walls e.g. arterioles, capillaries and venules, increased permeability of fluids including e.g. plasma proteins and increased blood flow. Increased vascular leakage often results in extravasation and oedema formation which characterize the damage of different tissues. Often tissue damage and inflammatory conditions are characterized by signs of pain, heat, redness, swelling and loss of function. Tissue damage is not defined as a disease per se but is often a component in different diseases of both acute or chronic nature.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PERSTORP ABSWEDEN SEGELTORP STOCKHOLM

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gustafsson, Torgny Perstorp, SE 3 11
Persson, Lars Hassleholm, SE 89 642
Rehnberg, Nicola Perstorp, SE 11 63

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation